Catherine
Hu
SVP, Investor Relations & Corp Comms
About
Catherine
Catherine Hu joined ElevateBio in 2021 to lead the company’s investor relations and corporate affairs functions. Prior to ElevateBio, Catherine led investor relations, corporate affairs, and patient advocacy functions at Scholar Rock, Inc. and was part of the investor relations team at Alexion Pharmaceuticals.
Catherine spent over a decade as an equity research analyst covering biopharmaceuticals and medical devices at various investment banks, including Bank of America, Barclays, Credit Suisse, and Deutsche Bank.
Education and Accomplishments
Catherine received her BS from New York University Leonard N. School of Business.
At ElevateBio, we are dedicated to driving innovation forward for the cell and gene therapy industry by rewriting genes, regenerating cells, and redefining manufacturing, right from the start.
